| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Special Articles |
Departments of Surgery (J.A.S., R.U., M.A.Z.), Medicine (N.R.P., M.A.L.), and Pathology (M.A.L.) and the Robert Wood Johnson Clinical Scholars Program (J.A.S., N.R.P.), The Johns Hopkins University School of Medicine, and the Departments of Epidemiology (N.R.P.) and Health Policy and Management (N.R.P.), The Johns Hopkins University School of Hygiene and Public Health, Baltimore, Maryland 21287
Address all correspondence and requests for reprints to: Martha A. Zeiger, M.D., Division of Endocrine and Oncologic Surgery, Carnegie 681, The Johns Hopkins Hospital, 600 North Wolfe Street, Baltimore, Maryland 21287-8611. E-mail: mzeiger{at}welchlink.welch.jhu.edu
A 1991 NIH Consensus Development Conference statement provided recommendations for the management of patients with asymptomatic and minimally symptomatic primary hyperparathyroidism (1° HPT), but adherence to these guidelines has not been documented. We conducted a cross-sectional survey of North American members of the American Association of Endocrine Surgeons inquiring about surgeon and 1° HPT patient characteristics, thresholds for surgery, and clinical outcomes. Multivariate regression was used to assess the relationship of physician characteristics to practice patterns and outcomes.
Of 190 surgeons surveyed, 147 (77%) responded; 109 provided complete responses (57%). These surgeons spend 66% of their time in patient care and perform an average of 33 (range, 1130) parathyroidectomies/yr. More than 72% of 1° HPT patients who underwent surgery were asymptomatic or minimally symptomatic. High volume surgeons (>50 cases/yr) had significantly lower thresholds for surgery with respect to abnormalities in preoperative creatinine clearance, bone densitometry changes, and levels of intact PTH and urinary calcium compared to their low volume colleagues (115 cases/yr). Overall reported surgical cure rates were 95.2% after primary operation and 82.7% after reoperation. Compared to high volume surgeons, low volume endocrine surgeons had significantly higher complication rates after primary operation (1.9% vs. 1.0% respectively; P < 0.01) and reoperation (3.8% vs. 1.5%; P < 0.001) as well as higher in-hospital mortality rates (1.0% vs. 0.04%; P < 0.05).
Endocrine surgeons operate on a large number of asymptomatic or minimally symptomatic 1° HPT patients. Even among a group of highly experienced surgeons who typically see patients after referral from endocrinologists, clinical outcomes and criteria for surgery vary widely and appear to be associated with surgeon experience. Their criteria for surgery diverge from NIH guidelines. These results implore the endocrine community to examine the evidential basis for decisions made in the management of 1° HPT.
This article has been cited by other articles:
![]() |
N. A. Johnson, M. E. Tublin, and J. B. Ogilvie Parathyroid Imaging: Technique and Role in the Preoperative Evaluation of Primary Hyperparathyroidism Am. J. Roentgenol., June 1, 2007; 188(6): 1706 - 1715. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Sejean, S. Calmus, I. Durand-Zaleski, P. Bonnichon, P. Thomopoulos, C. Cormier, P. Legmann, B. Richard, X. Y Bertagna, and G. M Vidal-Trecan Surgery versus medical follow-up in patients with asymptomatic primary hyperparathyroidism: a decision analysis Eur. J. Endocrinol., December 1, 2005; 153(6): 915 - 927. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. J. Strewler A 64-Year-Old Woman With Primary Hyperparathyroidism JAMA, April 13, 2005; 293(14): 1772 - 1779. [Full Text] [PDF] |
||||
![]() |
C. Morrison, W. Farrar, J. Kneile, N. Williams, Y. Liu-Stratton, A. Bakaletz, M. A. Aldred, and C. Eng Molecular Classification of Parathyroid Neoplasia by Gene Expression Profiling Am. J. Pathol., August 1, 2004; 165(2): 565 - 576. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-Y. Lo, W.-F. Chan, A. W. C. Kung, K.-Y. Lam, S. C. F. Tam, and K. S. L. Lam Surgical Treatment for Primary Hyperparathyroidism in Hong Kong: Changes in Clinical Pattern Over 3 Decades Arch Surg, January 1, 2004; 139(1): 77 - 82. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. G. Barker II, A. Klibanski, and B. Swearingen Transsphenoidal Surgery for Pituitary Tumors in the United States, 1996-2000: Mortality, Morbidity, and the Effects of Hospital and Surgeon Volume J. Clin. Endocrinol. Metab., October 1, 2003; 88(10): 4709 - 4719. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Kebebew, Q.-Y. Duh, and O. H. Clark Parathyroidectomy for Primary Hyperparathyroidism in Octogenarians and Nonagenarians: A Plea for Early Surgical Referral Arch Surg, August 1, 2003; 138(8): 867 - 871. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. Chow, W. B. Chan, J. K. Y. Li, N. N. Chan, M. H. M. Chan, G. T. C. Ko, K. W. Lo, and C. S. Cockram Oral Alendronate Increases Bone Mineral Density in Postmenopausal Women with Primary Hyperparathyroidism J. Clin. Endocrinol. Metab., February 1, 2003; 88(2): 581 - 587. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. N. Fahy, R. J. Bold, L. Beckett, and P. D. Schneider Modern Parathyroid Surgery: A Cost-benefit Analysis of Localizing Strategies Arch Surg, August 1, 2002; 137(8): 917 - 923. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. B. Inabnet III, C. K. Kim, R. S. Haber, and R. A. Lopchinsky Radioguidance Is Not Necessary During Parathyroidectomy Arch Surg, August 1, 2002; 137(8): 967 - 970. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Okamoto, T. Kamo, and T. Obara Outcome Study of Psychological Distress and Nonspecific Symptoms in Patients With Mild Primary Hyperparathyroidism Arch Surg, July 1, 2002; 137(7): 779 - 783. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Hindie, D. Melliere, C. Jeanguillaume, P. Urena, C. deLabriolle-Vaylet, and L. Perlemuter Unilateral Surgery for Primary Hyperparathyroidism on the Basis of Technetium Tc 99m Sestamibi and Iodine 123 Subtraction Scanning Arch Surg, December 1, 2000; 135(12): 1461 - 1468. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Siminoski Asymptomatic hyperparathyroidism: Is the pendulum swinging back? Can. Med. Assoc. J., July 1, 2000; 163(2): 173 - 175. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |